Dorothy Starling, PA
Payments from drug & device makers
Across 605 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Novartis$930
- Lilly USA, LLC$766
- Sun Pharmaceutical Industries Inc.$748
- UCB, Inc.$722
- plus $3K from 25 others
What the payments were for
- Food & beverage$10,18895%
- Education$5355%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 153 | $2,191 |
| Johnson & Johnson | 91 | $2,023 |
| Novartis | 64 | $930 |
| Lilly USA, LLC | 40 | $766 |
| Sun Pharmaceutical Industries Inc. | 46 | $748 |
| UCB, Inc. | 33 | $722 |
| Amgen | 37 | $717 |
| E.r. Squibb & Sons, L.L.C. | 29 | $344 |
| Regeneron Healthcare Solutions, Inc. | 10 | $256 |
| Incyte Corporation | 14 | $235 |
| Sanofi | 11 | $224 |
| Galderma Laboratories, L.p. | 8 | $217 |
| Boehringer Ingelheim | 7 | $161 |
| LEO Pharma Inc. | 9 | $161 |
| Mayne Pharma Commercial LLC | 12 | $151 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $150 |
| Arcutis Biotherapeutics, Inc. | 3 | $120 |
| Biofrontera Inc. | 4 | $86 |
| Kyowa Kirin, Inc. | 4 | $82 |
| Pfizer | 5 | $78 |
| Smith+Nephew | 2 | $56 |
| Dermavant Sciences, Inc. | 2 | $45 |
| Paratek Pharmaceuticals, Inc. | 2 | $43 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $39 |
| Verrica Pharmaceuticals Inc. | 2 | $38 |
| Organon | 2 | $34 |
| Organogenesis Inc. | 1 | $29 |
| LNHC, Inc | 1 | $24 |
| Genentech USA, Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $19 |
| Mission Pharmacal Company | 1 | $15 |
How this compares
$10,723 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 18 | $369,644 |
| Dupixent PenDupilumab | 50 | $189,181 |
| Ketoconazole | 126 | $1,854 |
| Clindamycin Phosphate | 38 | $1,637 |
| Triamcinolone Acetonide | 125 | $1,063 |
| Metronidazole | 40 | $851 |
| Clobetasol Propionate | 58 | $732 |
| Betamethasone Dipropionate | 27 | $731 |
| Fluorouracil | 16 | $719 |
| Ammonium Lactate | 28 | $582 |
| Ciclopirox | 17 | $234 |
| Doxycycline Hyclate | 20 | $232 |
| Fluconazole | 17 | $91 |
| Prednisone | 16 | $74 |
| Mupirocin | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Other medical in Troy
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.